Italy Atrial Fibrillation Market Size & Outlook, 2026-2033
The atrial fibrillation market in Italy is expected to reach a projected revenue of US$ 1,444.5 million by 2033. A compound annual growth rate of 10.2% is expected of Italy atrial fibrillation market from 2026 to 2033.
Revenue, 2025 (US$M)
$667.4
Estimate, 2026 (US$M)
$731.6
Forecast, 2033 (US$M)
$1,444.5
CAGR, 2026 - 2033
10.2%
Global Market
Related Markets
Italy atrial fibrillation market highlights
- The Italy atrial fibrillation market generated a revenue of USD 667.4 million in 2025 and is expected to reach USD 1,444.5 million by 2033.
- The Italy market is expected to grow at a CAGR of 10.2% from 2026 to 2033.
- In terms of segment, pharmacological treatment was the largest revenue generating treatment type in 2025.
- Pharmacological Treatment is the most lucrative treatment type segment registering the fastest growth during the forecast period.
Atrial fibrillation market data book summary
| Market revenue in 2025 | USD 667.4 million |
| Market revenue in 2033 | USD 1,444.5 million |
| Growth rate | 10.2% (CAGR from 2026 to 2033) |
| Largest segment | Pharmacological treatment |
| Fastest growing segment | Pharmacological Treatment |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pharmacological Treatment, Non Pharmacological Treatment |
| Key market players worldwide | AtriCure Inc, Boehringer Ingelheim, Boston Scientific Corp, Bristol-Myers Squibb Co, Sanofi SA, Johnson & Johnson, Abbott Laboratories |
Other key industry trends
- In terms of revenue, Italy accounted for 2.3% of the global atrial fibrillation market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Europe, Germany atrial fibrillation market is projected to lead the regional market in terms of revenue in 2033.
- Sweden is the fastest growing regional market in Europe and is projected to reach USD 461.4 million by 2033.
No credit card required*
Publish Date: Jan 07, 2026
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Atrial Fibrillation Market Scope
Atrial Fibrillation Market segmentation & scope
Treatment Type
Pharmacological Treatment
Non Pharmacological Treatment
End Use
Hospitals
Speciality Clinics
Others
Atrial Fibrillation Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Johnson & Johnson | View profile | 134,400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | www.jnj.com |
| Abbott Laboratories | View profile | 114,000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | www.abbottinvestor.com |
| Boston Scientific Corp | View profile | 48,000 | 300 Boston Scientific Way, Marlborough, MA, United States, 01752-1234 | www.bostonscientific.com |
| Sanofi SA | View profile | 87,994 | 46, avenue de la Grande Armée, Paris, France, 75017 | www.sanofi.com |
| Bristol-Myers Squibb Co | View profile | 34,100 | Route 206 and Province Line Road, Princeton, New Jersey, NJ, United States, 08543 | www.bms.com |
| AtriCure Inc | View profile | 1,200 | 7555 Innovation Way, Mason, OH, United States, 45040 | www.atricure.com |
| Boehringer Ingelheim | View profile | 10001+ | Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe | www.boehringer-ingelheim.com/ |
Italy Atrial Fibrillation Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Atrial Fibrillation Market Outlook will help companies and investors design strategic landscapes.
Pharmacological Treatment was the largest segment with a revenue share of 73.7% in 2025.
Horizon Databook has segmented the Italy atrial fibrillation market based on pharmacological treatment, non pharmacological treatment covering the revenue growth of each sub-segment from 2021 to 2033.
- Italy Atrial Fibrillation Market Treatment Type Outlook (Revenue, USD Million , 2021-2033)
- Pharmacological Treatment
- Non Pharmacological Treatment
- Italy Atrial Fibrillation Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Hospitals
- Speciality Clinics
- Others
Reasons to subscribe to Atrial Fibrillation Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Atrial Fibrillation Market Outlook databook
- Our clientele includes a mix of Atrial Fibrillation Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy Atrial Fibrillation Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Italy Atrial Fibrillation Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Italy Atrial Fibrillation Market, 2021-2033 (US$M)
Italy atrial fibrillation market statistics, by treatment type, 2021-2033 (US$M)
